Data / Drug companies / LGM Pharma Solutions, LLC
LGM Pharma Solutions, LLC: 11 products in the FDA NDC directory, labeler code 79739
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
LGM Pharma Solutions, LLC (labeler code 79739) lists 11 products in the FDA National Drug Code Directory, covering 8 finished drugs by generic name. By type: 10 prescription drugs, 1 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 18, 2021.
The request: Watch LGM Pharma Solutions, LLC (FDA labeler code 79739): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 79739
- Products in commercial distribution
- 11
- Packages
- 20
- Finished drugs by generic name
- 8
- Prescription products
- 10
- Over the counter products
- 1
- Controlled substance products
- Schedule III 4
- Flagged as original packager
- 11 of 11 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- November 30, 2001
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 11 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 10 | 90.9% |
| Over the counter drugs | 1 | 9.1% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Nabumetone | 3 | 30 |
| Usodiol | 2 | 1 |
| Glycopyrrolate | 1 | 64 |
| Butalbital, acetaminophen, caffeine, and codeine phosphate | 1 | 2 |
| Butalbital, aspirin, cafeine, and codeine phosphate | 1 | 1 |
| Butalbital, aspirin, and caffeine | 1 | 5 |
| Butalbital, acetaminophen, and caffeine | 1 | 22 |
| Polyethylene glycol 3350, nf powder for solution, laxative | 1 | 2 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 5 | 45.5% |
| Tablet, film coated | 3 | 27.3% |
| Tablet | 2 | 18.2% |
| Powder, for solution | 1 | 9.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Nonsteroidal Anti-inflammatory Drug | 5 |
| Barbiturate | 4 |
| Central Nervous System Stimulant | 4 |
| Methylxanthine | 4 |
| Bile Acid | 2 |
| Opioid Agonist | 2 |
| Platelet Aggregation Inhibitor | 2 |
| Anticholinergic | 1 |
| Osmotic Laxative | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Butalbital, Aspirin, and Caffeine | 79739-7192 | Capsule | Generic drugs (ANDA) | October 18, 2021 |
| Ursodiol 400 mg | 79739-7144 | Capsule | Generic drugs (ANDA) | July 1, 2020 |
| Ursodiol 200 mg | 79739-7143 | Capsule | Generic drugs (ANDA) | July 1, 2020 |
| Nabumetone 1000 mg | 79739-7078 | Tablet, film coated | Generic drugs (ANDA) | September 4, 2019 |
| Nabumetone 750 mg | 79739-7077 | Tablet, film coated | Generic drugs (ANDA) | September 4, 2019 |
| Nabumetone 500 mg | 79739-7076 | Tablet, film coated | Generic drugs (ANDA) | September 4, 2019 |
| Butalbital, Acetaminophen, and Caffeine | 79739-7320 | Tablet | Generic drugs (ANDA) | November 1, 2018 |
| Glycopyrrolate | 79739-7097 | Tablet | Generic drugs (ANDA) | March 12, 2012 |
| Polyethylene Glycol 3350, NF Powder for Solution, Laxative | 79739-7116 | Powder, for solution | Generic drugs (ANDA) | October 7, 2009 |
| Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate | 79739-6670 | Capsule | Generic drugs (ANDA) | June 10, 2004 |
| Ascomp with Codeine | 79739-6094 | Capsule | Generic drugs (ANDA) | November 30, 2001 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.